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          With an incidence of 1 in 20,000 live born infants1, congenital complete atrioventricular 
block (CCAVB) is a rare disease. The aetiology is not completely understood. However, 
CCAVB may be isolated or combined with congenital heart diseases in up to 53% of affected 
individuals2. Isolated CCAVB is in up to 98% of the children associated with positive 
autoimmune   antibodies   in   the   maternal   serum   (anti-Ro/SS-A   and   anti-LA/SS-B)3,4. 
Interestingly, these antibodies are not specifically directed against the conduction system but 
also against normal myocardial cells and may cause myocarditis5,6. Affection of the conduction 
system can occur at different levels7. Histologically, the atrioventricular node tissue may be 
replaced by fibrous fatty tissue with variable involvement of the distal conduction system8. 
           The onset of clinical symptoms in patients with CCAVB is already antenatally in up to 
28%9, but can also occur only later in life. This is due to a variable degree of heart block and 
heart rate. Most of the symptoms are related to the slow heart rate: hydrops foetalis, heart failure 
of the neonate, exercise intolerance of the child. Longer pauses may cause praesyncope, syncope 
(classical Adams Stokes attacks) or even sudden cardiac death. Whether or not Cardiomegaly is 
mainly the result of a chronic compensatory increased stroke volume secondary to the slow heart 
rate is somewhat controversial10. Cardiomegaly may also be a distinct disease in a subgroup of 
patients because it does not necessarily resolve with pacemaker (PM) therapy11,12. Morbidity 
and mortality of CCAVB do not seem to correlate with antibody status or associated cardiac 
lesions13,14. There are case reports, that fetal CCAVB can be improved with steroids15. Rarely, 
CCAVB resolves spontaneously16-19. In most patients, the degree of conduction abnormality 
will   either   persist   or   worsen   over   time.                                  
            There is no causal therapy for CCAVB. Permanent pacing is the only possible therapy. 
The aim of PM therapy is to prevent sudden cardiac death and to restore an adequate heart rate to 
avoid any secondary effects of longstanding bradycardia.                                             
            In our clinical practice, the ACC/AHA/NASPE guidelines for PM implantation proved to 
be useful20. Although one has to keep in mind that because of the rareness of the disease and the 
lack of large randomized trials, the level of evidence is usually low and most of these 
recommendations are based on experts opinions only.                                                   
            The following patients with CCAVB should undergo permanent pacing (Fig 1): First, all 
patients with advanced second- or third- degree AV block with symptomatic bradycardia, 
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exercise intolerance or low cardiac output. In children, symptoms can be subtle. In young 
children there may be poor growth and development, sleep disturbances including night - terror 
and bed wetting, frequent naps compared to peers and preference for a more sedentary behavior. 
School children may show poor school performance secondary to tiredness, the need to nap or to 
go to bed very early after school, irritability, and inability to keep up with peers during exercise 
13. Patients and parents tend to accept and adapt to minor symptoms and recognize them only in 
retrospect. Often, restored normal heart rates and the chronotropic competence after PM 
implantation lead to an exciting and motivating gain in energy and perseverance, which can 
change the personality of the child from lazy and lethargic to energetic and quick. 
 
 
 
Fig 1: Management of Patients with congenital compete heart block. For details see text.
            Second, patients with ECG changes believed to be associated with an increased risk for 
life threatening arrhythmias such as an unstable escape rhythm, sinus tachycardia, wide QRS 
escape rhythm, prolonged QT interval or ventricular arrhythmia20. The level of evidence is best 
for the latter two19,21. Long RR pauses are acceptable up to 3 seconds while awake or 5 seconds 
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while sleeping13. Ambulatory ECG monitoring with frequent episodes of junctional exit block, 
flat junctional response or associated tachyarrhythmias have been noted in patients with adverse 
outcomes22 but are not generally accepted as risk factors for sudden death.
            Third, patients with cardiomegaly11,12,23 or ventricular dysfunction20. In some patients, 
cardiomegaly is part of a dilated cardiomyopathy which can still progress in spite of PM 
therapy11,12. In most patients a decrease in left ventricular size and an improved myocardial 
function has been demonstrated after PM implantation23. 
            The lower limits of an acceptable escape rhythm might be around 55 bpm in neonates 
and 50 bpm in patients older than one year with the patient being awake and at rest20. In a 
prospective study of 27 patients with CCAVB and a mean age of 6.8 years 8 of 13 patients with 
mean daytime rates below 50 bpm in ambulatory ECG monitoring had cardiac complications 
such as sudden cardiac death (n=3), syncope, praesyncope or excessive fatigue22.
             The indication for a PM implantation is also given in patients with CCAVB and 
significant congenital heart diseases (i.e. those with cyanotic heart disease, single ventricle 
physiology, complete AVSD or significant AV valve disease)13. Again, this recommendation is 
not strictly evidence based but in these children, the haemodynamic status is often jeopardized 
from many reasons and restoring a normal heart rate and AV synchrony is often followed by a 
general   improvement   and   well   being.                                  
            Unfortunately, a large number of patients with CCAVB do not fall in the categories 
mentioned above and need an individual assessment. In most of these asymptomatic patients 
without specific changes in ECG or echocardiography we would still follow a permanent pacing 
strategy. We have to balance carefully the risks and disadvantages of a PM implantation against 
the risk of sudden cardiac death. The acceptance of a permanent PM by patients as well as 
parents is usually extremely good. There are however some specific age and size related 
particularities.
            We try to achieve a haemodynamic situation as close as possible to the normal heart 
rhythm. Therefore we tend to implant dual chamber PM in most of the children. The 
miniaturizing of pulse generators nowadays allows for implanting dual chamber pacing systems 
in babies down to 1600g 24. In infants and small children we do have very good experiences with 
bipolar steroid-eluting epicardial pacing leads, attached to the right atrium and right ventricle by 
a median sternotomy (Fig 2) or fixed to the left atrium and left ventricle after a lateral 
thoracotomy. Since all of the children will need their PM for a lifetime, we push the age limit for 
transvenous pacing system towards preschool age in order to avoid intimal trauma and 
obstruction of large veins in order to preserve them for later PM - systems. It is necessary to 
leave enough length to the leads to allow for growth of the patient. We prefer devices with 
automatic threshold measurement and output adjustment (AutoCapture) to increase patient safety 
and to extend device service life since most of the patients will be paced continuously at 
relatively high rates25. Although some children are still asymptomatic during childhood most of 
the   patients   with   CCAVB   will   have   PM   therapy   when   reaching   adulthood19.  
            Patients with CCAVB without PM do need a close, at least yearly, follow-up with 12 
lead ECG, 24 hour Holter monitoring and echocardiography. Despite the absence of symptoms 
in childhood, 50% of the patients will develop symptoms in adulthood and 10% will die 
prematurely17,18,19. With regards to the ECG it is important to know that not only the AV 
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conduction can worsen over time but also prolonged QTc interval can appear the first time in 
adulthood in patients who previously had normal Qtc17,19.
            Patients with CCAVB may present with similar symptoms but in fact it is a mixed group 
of diseases with a variety of yet not clearly defined aetiologies. Therefore it is very difficult to 
predict the natural history. There is a lack of evidence with regards to risk factors predicting 
sudden cardiac death or syncope in patients with CCAVB. With newer PM technologies the 
indications for PM therapy in children have been extended over the last years so that patients 
without symptoms and without specific signs in ECG or echocardiography may also benefit 
from the advantages of a permanent PM.
 
Fig 2:  Dual chamber pacemaker with epicardial electrodes implanted through a median 
sternotomy in a newborn with complete heart block.
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